In order to establish whether our vertex-wise findings reflect the ‘penumbra’ of subsequent atrophy, longitudinal studies comprising a wider spectrum of cognitively normal APOE ɛ4 carriers, individuals with MCI and Alzheimer’s disease are warranted. This evidence concerns the gene APOE and Alzheimer disease.